Sprott Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,400
Closed -$390K 139
2017
Q2
$390K Sell
4,400
-6,100
-58% -$514K 0.01% 140
2017
Q1
$846K Sell
10,500
-1,650
-14% -$129K 0.04% 128
2016
Q4
$865K Sell
12,150
-431,950
-97% -$33.9M 0.07% 122
2016
Q3
$38.4M Sell
444,100
-2,900
-0.6% -$253K 1.36% 7
2016
Q2
$38.8M Sell
447,000
-280,900
-39% -$22.7M 2% 5
2016
Q1
$54.6M Buy
+727,900
New +$54.8M 4.28% 1

Other funds holding MDT

Sprott Inc's MDT Position: Q3 2017 in Review

Sprott Inc sold out of Medtronic (MDT) in Q3 2017, closing a stake of 4,400 shares — an estimated $390K sold.

Sprott Inc first reported a position in MDT in Q1 2016 and held it in 6 quarters. The position peaked at $54.6M in Q1 2016. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • Sprott Inc reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
  • Sprott Inc sold 4,400 Medtronic shares in Q3 2017, an estimated $390K.
  • Sprott Inc first reported a position in Medtronic in Q1 2016 and held it in 6 quarters.
  • Sprott Inc's Medtronic position peaked at $54.6M in Q1 2016.
  • 1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Sprott Inc's 13F filing for Q3 2017, filed 3 Nov 2017.